Innovent Biologics, Inc. (HKG:1801)
Hong Kong · Delayed Price · Currency is HKD
85.50
+6.10 (7.68%)
At close: Mar 27, 2026
Revenue by Segment
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 13.04B | 9.42B | 6.21B | 4.56B | 4.27B | | | | | |
| 38.42% | 51.82% | 36.21% | 6.71% | 11.08% | | | | | |
| 13.04B | 9.42B | 6.21B | 4.56B | 4.27B | | | | | |
| 38.42% | 51.82% | 36.21% | 6.71% | 11.08% | | | | | |
Revenue by Geography
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
The People's Republic of China (PRC) | 12.07B | 8.98B | 5.75B | 4.13B | 3.97B | | | | | |
The People's Republic of China (PRC) Growth | 34.35% | 56.14% | 39.22% | 4.16% | 62.16% | | | | | |
The United State of Americas | 380.61M | 411.59M | 442.60M | 411.03M | 261.64M | | | | | |
The United State of Americas Growth | -7.53% | -7.01% | 7.68% | 57.10% | -81.27% | | | | | |
| 571.81M | - | - | - | - | | | | | |
| 19.63M | 26.88M | 10.12M | 12.81M | - | | | | | |
| -26.97% | 165.49% | -20.95% | - | - | | | | | |
| - | - | - | - | 6.60M | | | | | |
| - | - | - | - | 33.97M | | | | | |
| 13.04B | 9.42B | 6.21B | 4.56B | 4.27B | | | | | |
| 38.42% | 51.82% | 36.21% | 6.71% | 11.08% | | | | | |
Source: S&P Global Market Intelligence.
